Drug intelligence / Profile preview

COVID-19 animal feed vaccine

Development stage
Preclinical
Lead developer
PlantPharm BioMed
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Oral
01

Overview

The COVID-19 animal feed vaccine is a plant-based oral vaccine candidate developed by PlantPharm BioMed for the prevention of SARS-CoV-2 infection in animals. Developed at the request of the USDA Animal and Plant Health Inspection Service (APHIS), the vaccine utilizes a plant-based expression system to produce COVID-19 antigens within edible plant tissues. These plants are then processed into a pelletized feed format for oral administration. The mechanism of action involves the delivery of these antigens to the animal's gastrointestinal tract to stimulate a protective immune response, potentially offering a scalable solution for managing zoonotic transmission and protecting wildlife or livestock populations.

Other names
COVID-19 pelletized feed vaccineCOVID19 pelletized feed vaccineCOVID 19 pelletized feed vaccineanimal feed vaccine (COVID-19)
02

Targets

SARS-CoV-2 spike

Beyond the preview

Go deeper on COVID-19 animal feed vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COVID-19 animal feed vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call